tiprankstipranks
Genmab (Otc) (GMAB)
NASDAQ:GMAB
US Market
GMAB
Genmab
RESEARCH TOOLSreports
Want to see GMAB full AI Analyst Report?

Genmab (GMAB) Financial Statements

808 Followers

Genmab Financial Overview

Genmab's market cap is currently $18.75B. The company's EPS TTM is $1.277; its P/E ratio is 25.46; Genmab is scheduled to report earnings on August 6, 2026, and the estimated EPS forecast is $0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.72Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.42B
Gross Profit$ 3.41Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.42B
Operating Income$ 1.25Bkr 6.70Bkr 5.32Bkr 6.27Bkr 2.95B
EBITDA$ 1.34Bkr 9.70Bkr 5.95Bkr 7.35Bkr 4.18B
Net Income$ 963.76Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Balance Sheet
Cash & Short-Term Investments$ 1.71Bkr 21.10Bkr 28.14Bkr 22.32Bkr 19.34B
Total Assets$ 12.84Bkr 45.81Bkr 35.29Bkr 30.12Bkr 24.63B
Total Debt$ 5.43Bkr 1.03Bkr 770.00Mkr 597.00Mkr 425.00M
Net Debt$ 3.71Bkr -8.83Bkr -14.10Bkr -9.30Bkr -8.53B
Total Liabilities$ 7.01Bkr 9.11Bkr 3.68Bkr 2.84Bkr 2.43B
Stockholders' Equity$ 5.83Bkr 36.70Bkr 31.61Bkr 27.28Bkr 22.20B
Cash Flow
Free Cash Flow$ 1.15Bkr 7.58Bkr 7.00Bkr 3.60Bkr 1.98B
Operating Cash Flow$ 1.19Bkr 7.77Bkr 7.38Bkr 3.91Bkr 2.23B
Investing Cash Flow$ -5.65Bkr -9.91Bkr -1.28Bkr -2.76Bkr -961.00M
Financing Cash Flow$ 4.79Bkr -3.92Bkr -606.00Mkr -789.00Mkr -420.00M

Genmab Earnings and Revenue History

Income Statement >

Genmab Debt to Assets

Balance Sheet >

Genmab Cash Flow

Cash Flow >

Genmab Forecast EPS vs Actual EPS

Earnings >